Benefits of utilizing gene-modified iPSCs for clinical applications.
暂无分享,去创建一个
H. Okano | N. Benvenisty | W. Stanford | M. Sadelain | M. Porteus | J. Ellis | C. Baum | G. Mostoslavsky
暂无分享,去创建一个
H. Okano | N. Benvenisty | W. Stanford | M. Sadelain | M. Porteus | J. Ellis | C. Baum | G. Mostoslavsky